Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.44 - $1.22 $2,730 - $7,571
-6,206 Reduced 38.93%
9,736 $6,000
Q4 2023

Feb 13, 2024

SELL
$0.23 - $1.74 $1,248 - $9,446
-5,429 Reduced 25.4%
15,942 $8,000
Q3 2023

Nov 14, 2023

SELL
$1.41 - $2.31 $14,671 - $24,035
-10,405 Reduced 32.74%
21,371 $31,000
Q2 2023

Aug 21, 2023

SELL
$1.5 - $3.04 $110,982 - $224,923
-73,988 Reduced 69.96%
31,776 $51,000
Q1 2023

May 09, 2023

SELL
$2.8 - $5.46 $3,427 - $6,683
-1,224 Reduced 1.14%
105,764 $306,000
Q4 2022

Feb 14, 2023

BUY
$2.85 - $5.18 $5,882 - $10,691
2,064 Added 1.97%
106,988 $350,000
Q3 2022

Nov 18, 2022

SELL
$2.85 - $8.73 $4,428 - $13,566
-1,554 Reduced 1.46%
104,924 $397,000
Q2 2022

Aug 15, 2022

BUY
$4.69 - $9.84 $21,728 - $45,588
4,633 Added 4.55%
106,478 $829,000
Q1 2022

May 16, 2022

SELL
$8.44 - $16.89 $53,948 - $107,960
-6,392 Reduced 5.91%
101,845 $946,000
Q4 2021

Feb 15, 2022

BUY
$14.7 - $19.89 $75,837 - $102,612
5,159 Added 5.0%
108,237 $1.71 Million
Q3 2021

Nov 15, 2021

SELL
$11.99 - $17.9 $129,899 - $193,928
-10,834 Reduced 9.51%
103,078 $1.85 Million
Q2 2021

Aug 16, 2021

SELL
$12.89 - $16.58 $90,616 - $116,557
-7,030 Reduced 5.81%
113,912 $1.77 Million
Q1 2021

May 18, 2021

BUY
$14.0 - $20.72 $90,440 - $133,851
6,460 Added 5.64%
120,942 $1.74 Million
Q4 2020

Feb 16, 2021

BUY
$12.67 - $26.23 $62,754 - $129,917
4,953 Added 4.52%
114,482 $2.25 Million
Q3 2020

Nov 17, 2020

BUY
$11.92 - $15.87 $273,659 - $364,343
22,958 Added 26.52%
109,529 $1.42 Million
Q2 2020

Aug 17, 2020

BUY
$7.53 - $14.93 $66,331 - $131,518
8,809 Added 11.33%
86,571 $1.26 Million
Q1 2020

May 13, 2020

SELL
$5.69 - $17.78 $4,990 - $15,593
-877 Reduced 1.12%
77,762 $662,000
Q4 2019

Feb 14, 2020

SELL
$10.89 - $16.79 $17,293 - $26,662
-1,588 Reduced 1.98%
78,639 $1.3 Million
Q3 2019

Nov 15, 2019

BUY
$12.03 - $19.94 $143,445 - $237,764
11,924 Added 17.46%
80,227 $1.13 Million
Q2 2019

Aug 14, 2019

BUY
$19.05 - $41.04 $77,685 - $167,361
4,078 Added 6.35%
68,303 $1.37 Million
Q1 2019

May 09, 2019

SELL
$28.4 - $41.74 $40,555 - $59,604
-1,428 Reduced 2.18%
64,225 $2.55 Million
Q4 2018

Feb 13, 2019

BUY
$30.9 - $42.97 $45,732 - $63,595
1,480 Added 2.31%
65,653 $2.28 Million
Q3 2018

Nov 14, 2018

BUY
$35.05 - $43.5 $68,347 - $84,825
1,950 Added 3.13%
64,173 $2.65 Million
Q2 2018

Aug 14, 2018

BUY
$35.15 - $51.45 $425,771 - $623,213
12,113 Added 24.17%
62,223 $2.29 Million
Q1 2018

May 15, 2018

BUY
$18.0 - $48.35 $143,118 - $384,430
7,951 Added 18.86%
50,110 $1.95 Million
Q4 2017

Feb 14, 2018

BUY
$13.2 - $18.1 $24,235 - $33,231
1,836 Added 4.55%
42,159 $763,000
Q3 2017

Nov 13, 2017

BUY
$13.25 - $17.05 $534,279 - $687,507
40,323
40,323 $667,000

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $776M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.